Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: August 29, 2026 at 8:33 AM UTC
| NCT Number | NCT05512390 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 154 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 28, 2026 (Yesterday) |
As of August 29, 2026: Clinical trial NCT05512390 is currently active_not_recruiting participants. This phase1 study for diffuse large b-cell lymphoma is not currently accepting new participants at 8 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05512390 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05512390 was last updated Yesterday (August 28, 2026). HelloStudys verifies this status automatically.